Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2.

Florio, T; Thellung, S; Arena, S; Corsaro, A; Bajetto, A; Schettini, G; Stork, P J

Florio, T; Thellung, S; Arena, S; Corsaro, A; Bajetto, A; Schettini, G; Stork, P J.

Affiliation

Florio T; Pharmacology and Neuroscience, National Institute for Cancer Research (IST) and Advanced Biotechnology Center (CBA), Genova, Italy. florio@sirio.cba.unige.it

J Physiol Paris ; 94(3-4): 239-50, 2000.

Article in En | MEDLINE | ID: mdl-11088001

Subject(s)

MAP Kinase Signaling System/physiology; Protein Tyrosine Phosphatases/metabolism; Receptors, Somatostatin/metabolism; Animals; CHO Cells; Cell Division/physiology; Cricetinae; Cyclin-Dependent Kinase Inhibitor p21; Cyclins/metabolism; Intracellular Signaling Peptides and Proteins; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Protein Tyrosine Phosphatases / Receptors, Somatostatin / MAP Kinase Signaling System Limits: Animals Language: En Journal: J Physiol Paris Year: 2000 Document type: Article

Search on Google

XML

PubMed Links